Mon., November 6, 2023 | The Associated Press Share Share

周一。，2023年11月6日|相关新闻分享

SAN JUAN, Puerto Rico (AP) — One of Puerto Rico’s biggest distributors of pharmaceutical drugs was ordered to pay $12 million after being accused of not reporting hundreds of suspicious orders for controlled substances, the U.S. Justice Department said Monday.Drogueria Betances, LLC is accused of not reporting at least 655 orders for fentanyl and at least 113 orders for oxycodone from 2016 through June 2019.

美国司法部星期一表示，波多黎各圣胡安（AP）-波多黎各最大的药品分销商之一-被指控未报告数百份可疑的受控物质订单后，被命令支付1200万美元.Drogueria Betances，LLC被指控在2016年至2019年6月期间未报告至少655份芬太尼订单和至少113份羟考酮订单。

The orders were considered suspicious given in part their frequency and size, the department said.The company also is accused of hundreds of record-keeping violations and of not submitting reports of its distribution transactions to the U.S. Drug Enforcement Administration, including those involving opioids, from May 2017 to July 2018, officials said.In addition, the company was ordered to improve its compliance program and report suspicious orders to the DEA, among other things.Drogueria Betances said in a statement that while it agreed to pay the fine and strengthen its system to report the distribution of controlled substances, it rejected allegations that it had an inefficient system to monitor suspect orders.“Over the past years, we have made million-dollar investments in technology and external advice to ensure strict compliance with the laws and regulations that apply to controlled medications,” Juan Carlos Hernández, the company's president, said in a statement.He added that Drogueria Betances never was accused of diverting controlled products to unauthorized people or entities.The complaint filed by the U.S.

该部门表示，这些订单部分被认为是可疑的，部分原因是其频率和规模。官员说，该公司还被指控有数百例记录保存违规行为，并且未在2017年5月至2018年7月期间向美国药品监督管理局（包括涉及阿片类药物的药品监督管理局）提交其分销交易报告。此外，该公司还被命令改进其合规计划，并向DEA报告可疑订单等。Drogueria Betances在一份声明中表示，虽然它同意支付罚款并加强其报告受控物质分配的系统，但它拒绝了对其监测可疑命令的系统效率低下的指控。公司总裁胡安·卡洛斯·赫尔南德斯（Juan CarlosHernández）在一份声明中说：“在过去几年中，我们在技术和外部建议方面投入了数百万美元的投资，以确保严格遵守适用于控制药物的法律法规。他补充说，从未被指控将受控产品转移给未经授权的人或实体。美国提出的投诉。

government comes after the U.S. territory of 3.2 million people reported a surge in deadly overdoses related to opioids, from 19 deaths in 2017 to 521 in 2021, according to the newest available figures.Where should you invest $1,000 right now?Before you.

根据最新的数据，美国境内320万人报告说，与阿片类药物有关的致命过量剂量激增，从2017年的19人死亡到2021年的521人。你现在应该在哪里投资1000美元？在你之前。